ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PLSE vs ATRC // REVENUE GROWTH (YOY)

Pulse Biosciences Inc (NASDAQ) VS. AtriCure Inc. (NASDAQ) • 15-METRIC TALLY: PLSE 1 — ATRC 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PLSE VS. ATRC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PLSE ATRC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -30.00% 75.00% -105.00 ATRC /gross-margins <GO>
Return on Invested Capital (ROIC) -30.70% -1.90% -28.80 ATRC /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -1.38% 1.52% -2.90 ATRC /fcf-yield <GO>
Operating Margin -60.00% -1.80% -58.20 ATRC /operating-margins <GO>
Net Profit Margin -60.00% -2.10% -57.90 ATRC /net-margins <GO>
Revenue Growth (YoY) ACTIVE — 14.90% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 12.08 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 8/9 -6.00 ATRC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 59.7 66.0 -6.30 ATRC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $3.96B $3.18B $778.9M PLSE /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PLSE REV ATRC REV PLSE GROSS % ATRC GROSS % PLSE FCF ATRC FCF
FY 2025 $350.0K $534.5M -50.0% 75.0% -$54.4M $48.3M
FY 2024 $0 $465.3M — 74.7% -$36.5M $745.0K
FY 2023 $0 $399.2M — — -$33.0M $4.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PLSE // BETA —
ATRC // BETA —